A Benzamide-linked Small Molecule NDMC101 Inhibits NFATc1 and NF-κB Activity: A Potential Osteoclastogenesis Inhibitor for Experimental Arthritis

MLA

Hsu Shan Huang, et al. “A Benzamide-Linked Small Molecule NDMC101 Inhibits NFATc1 and NF-ΚB Activity: A Potential Osteoclastogenesis Inhibitor for Experimental Arthritis.” Journal of Clinical Immunology, vol. 32, Feb. 2012, pp. 762–77. EBSCOhost, https://doi.org/10.1007/s10875-012-9660-9.

APA

Hsu Shan Huang, Deh-Ming Chang, Chia Pi Cheng, Ming Jen Sheu, & Yu Chieh Hsu. (2012). A Benzamide-linked Small Molecule NDMC101 Inhibits NFATc1 and NF-κB Activity: A Potential Osteoclastogenesis Inhibitor for Experimental Arthritis. Journal of Clinical Immunology, 32, 762–777. https://doi.org/10.1007/s10875-012-9660-9

Chicago

Hsu Shan Huang, Deh-Ming Chang, Chia Pi Cheng, Ming Jen Sheu, and Yu Chieh Hsu. 2012. “A Benzamide-Linked Small Molecule NDMC101 Inhibits NFATc1 and NF-ΚB Activity: A Potential Osteoclastogenesis Inhibitor for Experimental Arthritis.” Journal of Clinical Immunology 32 (February): 762–77. doi:10.1007/s10875-012-9660-9.